These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 309586)

  • 21. [Bases for the use of immunosuppressive therapy in systemic connective tissue diseases].
    Rolović Z; Rolović M
    Srp Arh Celok Lek; 1971; 98(9):1177-85. PubMed ID: 5130860
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of immunosuppressive and anti-inflammatory drugs on lymphocyte population and MIF in glomerulonephritis.
    Janas-Boratyńska M; Szewczyk Z
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):833-45. PubMed ID: 398689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lessons for transplant immunosuppression from the usage of cyclosporine in autoimmune diseases.
    Bach JF
    Transplant Proc; 1994 Oct; 26(5):3077-81. PubMed ID: 7940966
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunosuppressive drugs and autoimmune diseases].
    Rossert J; Druet P
    Ann Biol Clin (Paris); 1991; 49(6):327-37. PubMed ID: 1759727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunosuppressive treatment and its side effects].
    Scheiffarth F
    Med Klin; 1971 Sep; 66(36):1183-9. PubMed ID: 4938064
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunosuppression trials in type I diabetes].
    Feutren G; Boitard C; Assan R; Bach JF
    Journ Annu Diabetol Hotel Dieu; 1987; ():147-69. PubMed ID: 3302472
    [No Abstract]   [Full Text] [Related]  

  • 27. Childhood vitiligo and tacrolimus: immunomodulating treatment for an autoimmune disease.
    Plettenberg H; Assmann T; Ruzicka T
    Arch Dermatol; 2003 May; 139(5):651-4. PubMed ID: 12756103
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunosuppression and immunomodulation.
    Goust JM; Stevenson HC; Galbraith RM; Virella G
    Immunol Ser; 1990; 50():481-98. PubMed ID: 2091765
    [No Abstract]   [Full Text] [Related]  

  • 29. [Current status of immunosuppressive therapy in non-neoplastic disorders].
    Grob PJ
    Schweiz Med Wochenschr; 1970 Apr; 100(16):703-7. PubMed ID: 4946733
    [No Abstract]   [Full Text] [Related]  

  • 30. The prospects of immunosuppression in type I diabetes.
    Bach JF; Feutren G; Boitard C
    Adv Nephrol Necker Hosp; 1988; 17():321-40. PubMed ID: 3124546
    [No Abstract]   [Full Text] [Related]  

  • 31. [The use of immunosuppressive agents for children].
    Lévêque B; Donea M
    Ann Pediatr (Paris); 1967 Mar; 14(3):248-57. PubMed ID: 5614549
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunosuppression].
    Amiel JL
    Minerva Med; 1970 Jul; 61(55):3022-7. PubMed ID: 5427676
    [No Abstract]   [Full Text] [Related]  

  • 33. [Our experience in the treatment of kidney diseases with immunosuppressive drugs].
    Popov NG; Astrug A; Gizov G; Kirov Ch; Iordanova S
    Vutr Boles; 1972; 11(3):115-7. PubMed ID: 4679963
    [No Abstract]   [Full Text] [Related]  

  • 34. [Round-table discussion on immunosuppressive agents in ophthalmology].
    Arch Ophtalmol Rev Gen Ophtalmol; 1972 Jan; 32(1):75-100. PubMed ID: 4261214
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT.
    Slavin S
    Bone Marrow Transplant; 1993 Jul; 12(1):85-8. PubMed ID: 8104072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current trends in the study of immunosuppressive agents].
    Uteshev BS
    Farmakol Toksikol; 1981; 44(1):5-12. PubMed ID: 6455303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunosuppressive therapy in auto-immune diseases i. general fundamentals (author's transl)].
    Sönnichsen N; Alberecht-Nebe H; Schulze P; Apostoloff E
    Dermatol Monatsschr; 1978 Nov; 164(11):769-78. PubMed ID: 363471
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases].
    Szegedi G
    Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B cell targeted therapies in autoimmune diseases.
    Isenberg DA
    J Rheumatol Suppl; 2006 May; 77():24-8. PubMed ID: 16652442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biology of Listeria infections. Effect of immunodepression].
    Touraine JL; Revillard JP; Traeger J
    Nouv Presse Med; 1972 Nov; 1(42):2827-32. PubMed ID: 4197510
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.